Aquatic Capital Management LLC

Position in INVA — Innoviva, Inc.

CIK 1803916 CHICAGO, IL

Position in INVA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,326,072

+$104,721 QoQ

Shares Held

56,913

-6.4% QoQ

Ownership

0.077%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Aquatic Capital Management LLC holds $123,092,373 across 91 Biotechnology names. INVA ranks #28 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	147,379	$11,066,689
2	ALNY	Alnylam Pharmaceuticals, Inc.	31,061	$10,277,153
3	EXEL	Exelixis, Inc.	194,571	$8,345,150
4	RPRX	Royalty Pharma plc	127,227	$6,103,079
5	ARWR	Arrowhead Pharmaceuticals, Inc.	80,227	$5,030,232
6	CYTK	Cytokinetics Inc	72,478	$4,777,024
7	XENE	Xenon Pharmaceuticals Inc.	79,199	$4,605,421
8	NKTR	Nektar Therapeutics	57,014	$4,102,157

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,326,072	56,913	-6.4%	Shares	Sole	2026-05-15
2025-06-30	$1,221,351	60,794	-7.8%	Shares	Sole	2025-08-14
2025-03-31	$1,194,893	65,907	+77.9%	Shares	Sole	2025-05-15
2024-12-31	$642,661	37,041	+13.6%	Shares	Sole	2025-02-14
2024-09-30	$629,506	32,600	+14.0%	Shares	Sole	2024-11-14
2024-06-30	$469,040	28,600	+6.3%	Shares	Sole	2024-08-14
2024-03-31	$409,956	26,900	+301.5%	Shares	Sole	2024-05-15
2023-06-30	$85,291	6,700	+157.7%	Shares	Sole	2023-08-14
2022-12-31	$34,450	2,600	-76.6%	Shares	Sole	2023-02-14
2022-09-30	$128,871	11,100	+37.0%	Shares	Sole	2022-11-14
2022-06-30	$119,556	8,100	+800.0%	Shares	Sole	2022-08-15
2022-03-31	$17,415	900	-85.5%	Shares	Sole	2022-05-16
2021-12-31	$106,950	6,200	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.